About 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole
5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole (PubChem CID 53391184) has the molecular formula C13H15N7S
and a molecular weight of 301.38 g/mol. Its IUPAC name is 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole.
Analyze 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole?
The IUPAC name of 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole (CID 53391184) is 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole.
What is the SMILES notation for 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole?
The canonical SMILES for 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole is CN1CCN(c2ncc(-c3cncs3)n3cnnc23)CC1.
What is the InChIKey of 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole?
The InChIKey is BQDRPPKMRJSPEU-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H15N7S/c1-18-2-4-19(5-3-18)12-13-17-16-8-20(13)10(6-15-12)11-7-14-9-21-11/h6-9H,2-5H2,1H3.
What are the key properties of 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole?
5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole has a molecular weight of 301.38 g/mol, XLogP of 1.00, 2 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[8-(4-methylpiperazin-1-yl)-[1,2,4]triazolo[4,3-a]pyrazin-5-yl]-1,3-thiazole is sourced from PubChem (CID 53391184), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).